Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
Professor Isidro Cortés-Ciriano, an internationally recognised scientist with extensive experience in childhood cancer research, will accelerate Oxford-Harrington’s mission to translate discoveries into new therapies for children with rare cancers
Continue Reading
New study of human cancers published in Science Signaling
Continue Reading
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic
Continue ReadingIn addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See All DiscoveriesBy concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.
Learn More